CA-ARMIS
14.2.2024 14:01:35 CET | Business Wire | Press release
Armis, the asset intelligence cybersecurity company, today announced it has agreed to acquire CTCI (Cyber Threat Cognitive Intelligence), a privately held company specializing in AI-powered pre-attack threat hunting technology.
In a private deal which closed this week, Armis has acquired all of CTCI technology and employees, expecting to merge the company with Armis over the next 30 days. Armis will integrate CTCI's technology into Armis Centrix™ to create the most advanced early warning cyber intelligence system in the world, helping security operations teams be more effective in preventing breaches, detecting attacks and determining if an organization has been compromised.
“In the face of continued, escalating cyber threats we recognize the importance of preempting an attack. It is time for the security community to redefine our operating paradigm by proactively finding and stopping attacks rather than taking action once the attack is launched,” said Yevgeny Dibrov, CEO and Co-Founder, Armis. “This acquisition signals our unwavering commitment to be the core platform that manages the entire attack surface. Enterprises and organizations leveraging Armis Centrix™ for Actionable Threat Intelligence will lead from a position of strength in managing their cyber exposure.”
An AI-native company, CTCI was founded in 2020 by CEO Andrew Grealy and CTO Michael Freeman. Leveraging Armis’ Asset Intelligence Engine and feeding CTCI’s proprietary intelligence database, Armis Centrix™ will provide early warning indicators based on intelligence from the dark web, AI-based honeypots and known adversaries to alert organizations of a potential breach or attack.
“Security teams receive a daily deluge of information and are often in a reactive security posture with little or no warning that they are targets for an attack,” said Andrew Grealy, CEO and Co-Founder, CTCI. “The fusion of Armis with its full visibility, security and control, combined with CTCI’s advanced AI, empowers organizations to take a proactive security stance and stop an attack before it is even launched.”
CTCI’s technology will be built into the Armis Centrix™ platform to create a revolutionary way of identifying and neutralizing threats before they are even launched. Leveraging a combination of AI and machine learning that scours the dark web, Armis Centrix™ for Actionable Threat Intelligence provides advanced visualization and alerts that will provide organizations with actionable intelligence before a vulnerability is announced, before an attack is even launched and before an organization is impacted.
As outlined in a recent blog, Armis is embarking on a bold 5 year strategy to create the leading cyber exposure management platform and the biggest asset intelligence company in the world. It plans to analyze various technologies as it grows its award-winning Armis Centrix™ platform to be the chosen solution for Fortune 100, 200 and 500 organizations and government entities around the world.
For more information you can visit our blog
About Armis
Armis, the asset intelligence cybersecurity company, protects the entire attack surface and manages the organization's cyber risk exposure in real time. In a rapidly evolving, perimeter-less world Armis ensures that organizations continuously see, protect and manage all critical assets. Armis secures Fortune 100, 200 and 500 companies as well as national governments, state and local entities to help keep critical infrastructure, economies and society stay safe and secure 24/7. Armis is a privately held company headquartered in California.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240214256441/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
